Results of Less Than 5-mm Right Ventricle-Pulmonary Artery Conduits in Single Ventricle Palliation

Ann Thorac Surg. 2021 Jun;111(6):2028-2032. doi: 10.1016/j.athoracsur.2020.05.171. Epub 2020 Aug 5.

Abstract

Background: Our programmatic approach to single ventricle (SV) neonatal palliation has evolved to using smaller-size right ventricle to pulmonary artery (RV-PA) conduits for pulmonary blood flow. Therefore, we sought to compare the early outcomes of less than 5-mm versus 5-mm RV-PA conduits in SV patients undergoing neonatal palliation.

Methods: We performed a retrospective review of SV patients who had neonatal palliation with either a less than 5-mm or 5-mm RV-PA connection, constructed using a waterproof, breathable fabric membrane graft (Gore-Tex, Flagstaff, AZ). Data before, during, and after surgery were analyzed using SPSS software.

Results: A total of 26 patients in group 1 (n = 11; <5 mm) and group 2 (n = 15; 5 mm) were operated on, with a mean follow-up of 13 months. Statistical differences (P ≤ .05) were noted with renal near-infrared spectroscopy (mean, 56 versus 44), and oxygen saturation at discharge (mean, 80% versus 85%) in groups 1 and 2, respectively. We found no significant difference in patient weight, peak lactate, cerebral near-infrared spectroscopy, length of intubation, length of hospitalization, or need for RV-PA conduit intervention after stage 1 along with age, branch PA sizes, or need for PA plasty at bidirectional Glenn between groups.

Conclusions: Our early results of less than 5-mm conduits support further exploration into the tailoring of the RV-PA conduit size for each patient. A smaller-diameter conduit may improve systemic cardiac output and net oxygen delivery. Larger patient cohorts and longer follow-up with assessment of pulmonary artery growth are warranted to guide clinical practice.

MeSH terms

  • Blood Vessel Prosthesis*
  • Female
  • Heart Ventricles / surgery
  • Humans
  • Infant, Newborn
  • Male
  • Norwood Procedures / instrumentation*
  • Palliative Care*
  • Polytetrafluoroethylene
  • Prosthesis Design
  • Pulmonary Artery / surgery*
  • Pulmonary Circulation
  • Retrospective Studies
  • Treatment Outcome
  • Univentricular Heart / surgery*

Substances

  • Polytetrafluoroethylene